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Abstract
Background: Blood culture surveillance will be used for assessing the public health effectiveness
of pneumococcal conjugate vaccines in Africa. Between 2003 and 2006 we assessed blood culture
outcome and performance in adult patients in the central public hospital in Blantyre, Malawi, before
and after the introduction of a dedicated nurse led blood culture team.
Methods: A prospective observational study.
Results: Following the introduction of a specialised blood culture team in 2005, the proportion of
contaminated cultures decreased (19.6% in 2003 to 5.0% in 2006), blood volume cultured increased
and pneumococcal recovery increased significantly from 2.8% of all blood cultures to 6.1%. With
each extra 1 ml of blood cultured the odds of recovering a pneumococcus increased by 18%.
Conclusion: Standardisation and assessment of blood culture performance (blood volume and
contamination rate) should be incorporated into pneumococcal disease surveillance activities
where routine blood culture practice is constrained by limited resources.
Background
Blood cultures are an essential component of good clini-
cal care in the diagnosis and management of blood stream
infections (BSI) which are frequent in hospitalised
patients in Malawi and the rest of Africa [1-6]. Informa-
tion from blood culture surveillance is also an important
tool for establishing public health priorities, assessing the
impact of interventions – particularly vaccines – and for
providing information on antimicrobial resistance pat-
terns to help formulate prescribing guidelines for empiri-
cal therapy. Blood culture surveillance has been the key
tool used in the USA for recognising the enormous poten-
tial of childhood pneumococcal conjugate vaccination for
decreasing disease in adults[7].
In Malawi as in much of the rest of sub-Saharan Africa,
blood culture facilities are available in only a limited
number of centres. As a consequence single reports are
often extrapolated as representative of disproportionately
large regions and time periods, and inaccuracies in these
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reports are more likely to be perpetuated as a result of the
lack of alternative data. Blood cultures need to be specific
and sensitive and therefore as representative as possible of
the true BSI disease burden and particularly so where BSI
surveillance is restricted to very few sites.
Isolation of bacteria from blood is usually taken as defin-
itive proof of disease aetiology; this is particularly true for
pneumococcal pneumonia where blood culture remains
the gold-standard for diagnosis. However blood cultures
lack sensitivity, which may vary as a result of both labora-
tory and clinical factors. Laboratory factors include choice
of culture media, speed of incubation and duration of
incubation. Among clinical factors recent receipt of antibi-
otics and poor collection technique leading to contamina-
tion decreases sensitivity, while culturing larger volumes
of blood generally increases the yield of positive results [8-
13]. Investigation of the relationship of blood volume to
recovery has tended to concentrate on large volumes of
blood in excess of 20 mls and not on the relatively smaller
volumes most typically taken during routine clinical prac-
tice in Africa.
The blood culturing service at the Queen Elizabeth Cen-
tral Hospital (QECH) in Blantyre, Malawi is the only large
scale, unselected and continuous assessment of BSI in
Malawi and thus provides information of national impor-
tance to health planners and researchers. Samples for
blood culture have traditionally been taken by nurses,
medical and paramedical staff in attendance on the wards
of the QECH. In March 2003 an audit of blood culture
performance was carried out in the medical wards, reveal-
ing poor collection technique and inadequate volumes of
collected blood. This information was fed back to staff
starting in January 2004 with regular updates throughout
that year but with little overall change in the outcome
(contamination rate and isolation rate) of blood cultures.
In January 2005 a dedicated team of nurses was estab-
lished to perform all the blood cultures in adult patients
in the QECH. This was a direct consequence of the failure
to measure an improvement in blood culture perform-
ance through feedback to the general clinical staff. We
report the changes in blood culture results following the
introduction of this team and relate bacterial isolation to
blood volume collected.
Methods
All of the work described has been carried out in the adult
medical wards of the Queen Elizabeth Central hospital
(QECH) between January 2003 and December 2006. The
QECH is the largest public hospital in Malawi and pro-
vides care for the more than one million residents in Blan-
tyre district and takes referrals from the southern region of
the country. The medical department has ~250 beds occu-
pied at any given time and admits ~10,000 patients annu-
ally.
In February-April 2003 an audit of blood culture tech-
nique and volume was undertaken. In January 2004 the
results of this audit were fed back to staff involved in
blood culture collection. Throughout 2004 there were reg-
ular updates of blood culture performance provided at
least monthly at medical department meetings and
including staff responsible for taking blood for culture.
When new staff arrived in the department, demonstra-
tions were given at three monthly intervals by study team
members on proper blood collection technique. In Janu-
ary 2005 a dedicated team of nurses was introduced with
responsibility to perform all blood cultures. Nurses were
chosen as no cadre of staff exist in Malawi with a license
to perform phlebotomy. These nurses were given appro-
priate training including laboratory visits and are super-
vised by a senior nurse manager. Whilst they also
undertake general nursing duties their work priority is the
performance of blood cultures. They take responsibility
for the management of physical resources required for
phlebotomy and liaison with the laboratory. If they
encounter a problem they have direct access to the nurse
manager. The results of blood cultures are returned to
patients and their medical team through the blood culture
nurses. Targets for contamination rates are set at 5%.
Blood cultures are requested by the admitting medical
officer. The majority of these staff change at regular inter-
vals after a few months in post but are encouraged to fol-
low departmental guidelines for ordering of blood
cultures. These include axillary temperature > 37.5°C or <
35.0°C, clinical syndrome of pneumonia, sepsis or men-
ingitis, any altered level of consciousness or any life
threatening illness as judged by the admitting officer.
These policies and guidelines for the selection of patients
for blood culture did not change throughout the period of
the present study. All departmental staff receive a small
printed copy of departmental protocols to be carried on
their person for reference and undergo a period of training
at the commencement of their attachment. There is no
regular formal audit of compliance with protocol.
Blood culture analysis is performed using an automated
system (BacTalert®, Bio-Merieux). Blood is removed from
the patient and transferred to a single aerobic blood cul-
ture bottle containing the manufacturer's standard culture
medium. Bottles are either placed in a ward-based incuba-
tor or transferred immediately to the microbiology labo-
ratory for processing, depending on the time of collection.
A count of blood culture bottles provided by the lab is
kept and compared to blood culture bottles received back
from the wards along with reports of bottle spoilage. This
process ensures all blood cultures taken are analysed.BMC Infectious Diseases 2008, 8:137 http://www.biomedcentral.com/1471-2334/8/137
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Processing of samples follows standard operating proce-
dures consistent with accepted laboratory practice. These
protocols have been unaltered over the four years of the
surveillance period. Isolation of Diphtheroids, coagulase
negative Staphylococci, Micrococci spp or Bacillus spp
other than anthracis is recorded as contaminants. All other
isolates are treated as significant.
Collected blood volume was measured during Feb/March,
2003 and Feb/March 2005. All blood cultures arriving in
the laboratory on Mondays and Thursdays were subjected
to assessment. Weight was measured by subtracting the
mean unfilled and uncapped blood culture bottle weight
from the weight of bottles delivered to the laboratory. The
mean weight of an unused bottle was estimated by
sequential measurements on 20 unused bottles. Weights
of unused bottles were highly consistent within each
period of assessment: in 2003 mean weight was 93.7 g,
(SD 0.15) and in 2005 it was 68.4 g, (SD 0.16) (blood cul-
ture bottle structure was changed during the intervening
period by the manufacturer). The staff in both the hospital
and laboratory were unaware that an assessment of blood
culture volumes was underway. In 2003 we assessed 500
bottles; in 2005 we measured 250 bottles. This would pro-
vide sufficient power to demonstrate a significant increase
in blood volume above a geometric mean of 5 mls.
Results of blood cultures are recorded in a Microsoft
Access® database. Statistical analysis was performed using
STATA8 software (College Station, Texas). Comparison of
blood volumes was performed using the unpaired Stu-
dent's t-test, the relationship between blood volume col-
lected and isolation rate was performed using logistic
regression analysis. Temporal changes in isolate recovery
were evaluated by comparing recovery rates in the pre-
blood culture nurse service years 2003/4 to the post blood
culture service years 2005/6 using the chi2 test.
No ethical approval was sought for this study as it used
routinely collected data. Analysis was undertaken on an
anonymised database.
Results
There was no significant change between 2003 and 2004
following the introduction of performance feedback to
staff (Table 1). Following the introduction of the blood
culture team in 2005, there was a significant decline in the
rate of retrieval of contaminants from blood cultures,
from 19.6% to 5.0% (Table 1). The quantity of blood col-
lected for culture also significantly increased during this
period, from a median of 4.6 to 9.7 mls per bottle (Table
1).
Non-typhoidal Salmonella and Streptococcus pneumonia
were the most frequently isolated organisms during all
three periods and made up 76.2, 68.2, 74.0 and 67.1% of
all significant isolates during the four study years respec-
tively. The other major isolates are detailed in Table 1. The
increased recovery of S. pneumoniae between 2003/4 and
2005/6 was highly significant with a 118% increase in iso-
lation. There was also a significant 25% decrease in the
recovery of non typhoidal Salmonella during these two
periods (p < 0.001), (Table 1). Amongst other isolates
Table 1: Total number of blood cultures taken and analysed over the four years 2003–2006 inclusive and the proportion of cultures 
growing a contaminant or significant isolate
Year 2003 2004 2005 2006 P1 OR2
Total blood cultures 7141 5709 6129 5650
Contaminants n(%) 1402(19.6) 1071(18.8) 442(7.2) 280(5.0) < 0.01 0.27
All significant isolates 1267(17.7) 931(16.3) 1203(19.6) 1020(18.1) < 0.01 1.13
S. pneumoniae 207(2.9) 152(2.7) 410(6.7) 310(5.5) < 0.01 2.26
non-typhoidal Salmonella 758(10.6) 483(8.5) 480(7.8) 374(6.6) < 0.01 0.73
C. neoformans 64(0.9) 53(0.9) 73(1.2) 118(2.1) < 0.01 1.79
E. coli 93(1.3) 76(1.3) 114(1.9) 115(2.0) < 0.01 1.48
Klebsiella spp 25(0.4) 24(0.4) 13(0.2) 12(0.2) 0.02 0.55
S. aureus 38(0.5) 43(0.8) 26(0.4) 16(0.3) < 0.01 0.56
Group A streptococcus 10(0.1) 12(0.2) 15(0.2) 15(0.3) 0.15
S. typhi 3(0.0) 3(0.1) 8(0.1) 11(0.2) < 0.01 3.46
Other Gram positive3 19(0.3) 34(0.6) 27(0.4) 16(0.3) 0.55
Other Gram negative4 50(0.7) 51(0.9) 37(0.6) 33(0.6) 0.07
Median volume ml (IQR) 4.6(0.3–10.1) 9.7(1.9–13.3)2 < 0.001
1 The p value has been derived by a two-way comparison comparing 2003/4 (pre-dedicated culture service) vs 2005/6 (post dedicated service) using 
a chi2 test. 2 The odds ratio of recovery during the 2005/6 blood culture intervention year compared to the pre-blood culture service period. 3 
Other Gram positive isolates were primarily non-pneumococcal alpha haemolytic Streptococci (72 of 96, 75%) 4 Other Gram negative isolates 
included Haemophilus spp. (16 of 171, 9.4%), Pseudomonas spp. (18, 10.5%), Neisseria meningitidis (14, 8.2%), Acinetobacter spp. (32, 18.7%), 
Enterobacter spp. (38, 22.4%) and other coliforms (53, 31.0%).BMC Infectious Diseases 2008, 8:137 http://www.biomedcentral.com/1471-2334/8/137
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there was a significant increase in recovery of E. coli, Cryp-
tococcus neoformans and Salmonella typhi.
Geometric mean blood volumes were highest in blood
cultures from which S. pneumoniae and C. neoformans were
recovered (Table 2). There was also a significant increas-
ing chance of recovering S. pneumoniae with larger blood
volumes cultured. Over the range of blood volumes col-
lected in this study, for every extra 1 ml of blood the odds
of recovering S. pneumoniae increased by 18%. This trend
was not seen for non typhoidal Salmonella. When
adjusted for year of recovery this finding persisted. There
was a trend for decreasing recovery of both other Gram-
negative and Gram-positive isolates with increased blood
volume. However the majority of these isolates were
recorded during the 2003 assessment period (35 vs 2)
which limits the validity of this comparison.
Discussion
The QECH is an important tertiary referral centre in
Malawi providing a blood culture service for patient care.
The results of blood cultures from this institution have
been reported in the past[6,14] and have helped deter-
mine clinical and research priorities and antibiotic pre-
scribing practice. Inadequacies of technique and
procedure in the sampling of blood for culture were cor-
rected during 2005 by the introduction of a team of blood
culture nurses. As a result of this we measured an
increased yield of blood culture isolates, an effect that was
most dramatic with the isolation of pneumococci. Our
findings suggest that surveillance for invasive pneumococ-
cal disease in our region should pay close attention to the
quality and quantity of blood collection at the bed-side.
The potential for selection bias in this study was low.
Blood cultures were ordered as a part of standard depart-
mental clinical care and unconnected with any of the
investigative team. Departmental indications for blood
cultures remained unchanged over the course of the study.
The proportion of all adult admissions sampled each year
remained relatively constant around 60% (data not
shown) suggesting that there was no fundamental change
in the individuals sampled that might bias sampling
towards respiratory illness and greater recovery of pneu-
mococcus. Over the four year period, data from active sur-
veillance on clinical presentation to hospital indicate no
secular trends in illness presentation in this population.
Inoculated blood volumes were assessed on a representa-
tive sample of blood cultures. Although the sample selec-
tion was not random the sampling method was unlikely
to lead to any systematic bias in isolate recovery or vol-
ume between the two assessment periods: clinical staff
were unaware of the blood culture volume assessment;
samples were taken from acute admissions; and as noted
above, there was no evidence of a major change in pattern
of clinical presentation during this period. Laboratory
practice was consistent throughout the duration of the
study.
The principal weakness of the study is the historical nature
of the comparison. We are unable to fully exclude the pos-
sibility of temporal shifts in the pattern of pneumococcal
disease and other significant isolates, or of changes in the
pattern of health seeking behaviour and population.
Pneumococcal disease does show seasonal varia-
tion[3,15]. By assessing blood volumes over similar sea-
sons in the two assessment years, we have minimised the
possible confounding effect of seasonal changes on the
relationship between sample volume and retrieval of S
pneumoniae. Longer term changes i.e. the possibility of a
steadily increasing burden of pneumococcal infection in
the community, are less easy to control for. Accessibility to
antiretrovirals (ART) for the HIV-infected and improve-
ments in health care access may have altered health seek-
ing patterns. There is no information from this region to
know if this is the case, although it is unlikely that this
would easily explain the rise in pneumococcal isolation
indeed access to ART might be expected to reduce disease
burden[16] and the number of health service facilities in
the region has remained the same over the period of the
study. Population size and structure within the hospital
catchment area is also subject to demographic change.
Table 2: Geometric mean blood volume cultured in relation to isolate recovery for 760 blood cultures assessed during the two 
surveillance periods in 2003 and 2005
N Mean volume ml 95% CI OR (95%CI) ORa (95%CI)
No growth 566 5.51 5.28–5.75
Contaminants 52 3.76 3.17–4.45
S. pneumoniae 31 6.71 5.69–7.93 1.18 (1.05–1.33) 1.29 (1.08–1.53)
Non typhi Salmonella 70 5.21 4.61–5.87 0.99 (0.90–1.07) 0.97 (0.86–1.09)
Cryptococcus neoformans 4 6.72 2.45–18.45 1.19 (0.86–1.65) 0.86 (0.61–1.20)
Other Gram negative 27 3.04 1.99–4.65
Other Gram positive 10 3.70 2.63–5.20
For clarity, Gram negative and Gram positive bacteria other than S. pneumoniae and the non-typhi Salmonella have been grouped together. Odds 
Ratios are presented unadjusted (OR) and adjusted (ORa) for year of sampling and represent the chances of recovering an isolate with each extra 
ml of blood over the range of volumes taken in this study 1–13 mls.BMC Infectious Diseases 2008, 8:137 http://www.biomedcentral.com/1471-2334/8/137
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However during the period of the study there has been no
major population shifts with annual growth estimated at
2.3%[17]. Urbanisation in Malawi is relatively slow com-
pared to other African countries and the prevalence of
adult HIV in this region has remained stable at around
12% which would suggest there has been no large influx
of susceptible individuals as an explanation for the
increased numbers of cases. There is no evidence to sup-
port a fundamental change in the behaviour and biology
of S. pneumoniae. Serotype distribution has remained rela-
tively constant over several years [18] with an absence of
any large epidemics of serotypes 1,3,5 or 12 which have
been associated with large outbreaks in sub-Saharan
Africa and elsewhere. Furthermore the demonstrated asso-
ciation between recovery, blood volume and reduced con-
tamination provides support to the view that increased
recovery is a function of sampling and not an epidemic
phenomenon.
The decrease in recovery of non typhoidal Salmonella is
less easy to explain. Salmonellae are potential skin con-
taminants in our setting as well as invasive pathogens in
their own right. Reduced skin contamination through
improved skin cleansing is probably the explanation for
the reduced recovery of Staphylococcus aureus and may also
be the case for our reduced recovery of other Gram nega-
tives. However temporal shifts in disease burden need to
be considered [19]. In the two years preceding this report
(2001 and 2002) recovery of non-typhoidal Salmonellae
and S. pneumoniae were recorded at a similar rate to that
recorded in 2003 (Salmonellae 8.0% and 10.1%, S. pneu-
moniae  2.2% and 2.5% respectively, unpublished data,
blood culture analysis using a manual method), which
suggests that temporal changes take place gradually over
long periods of time and that the findings reported in
2003 and 2004 are not unique in terms of recovery rates
of significant isolates. Increasing use of anti-retroviral
drugs during 2005 and 2006 may have reduced the inci-
dence of NTS bacteraemia in the adult population in Blan-
tyre. Longer term surveillance incorporating other centres
will be important to understand the evolving epidemiol-
ogy of BSI preferably nested in settings subjected to demo-
graphic surveillance.
The association between increased blood volume and
improved recovery of pneumococcus is not in itself sur-
prising. Past studies and accepted knowledge support the
view that greater volumes of blood improve the recovery
of microorganisms[8-13,20], although there are excep-
tions to this[21]. Similarly it is not surprising that there
should be a different relationship between volume and
isolation rate for different bacteria. The quantity of bacte-
ria in a given quantity of blood, the viability of these bac-
teria and their robustness during venesection,
inoculation, transportation, incubation and analysis will
all play a part. The failure to see increased recovery of non-
typhoidal salmonella with larger blood culture volumes
may reflect the ease of recovery of this organism from
individuals with advanced HIV, who are unable to control
the bacteraemia[22].
What is surprising from this study is the extent of the
change in recovery of pneumococci in relation to the
other principal blood culture isolates over the range of
blood volumes suitable for inoculation into a single
blood culture bottle. Single bottle inoculation has been
adopted as a routine as it minimises costs and also fits
with local cultural concerns over removal of blood. This
will be typical of many resource-limited settings. Our
findings are very different from a previous report in the
USA that recorded no change in the recovery of Gram pos-
itive organisms using the BacTalert® system comparing 5
and 10 ml inoculums[23]. This suggests a fundamentally
different host response to bacteraemia in our patient pop-
ulation which alters bacterial recovery and the high prev-
alence of HIV co-infection in over 70% of adult in-
patients is likely to be the major determining factor. Pneu-
mococcal bacteraemia is known to be more common dur-
ing respiratory infection in HIV-infected adults compared
to the HIV-uninfected[24,25]. A mechanism to explain a
differing volume/recovery relationship in the presence of
HIV is however not currently known.
Conclusion
These findings suggest we should be cautious about the
way we interpret and use data from routine blood culture
services where there are severe resource limitations.
Uncritical reporting may falsely skew and under-report
blood stream infections, especially S. pneumoniae bacter-
aemia. There are rapidly evolving initiatives to introduce
pneumococcal conjugate vaccines into the vaccination
schemes in developing nations. An important component
of this introduction will be the availability of reliable
pneumococcal disease surveillance for the monitoring of
both direct and indirect benefits, and serotype changes
induced by the vaccine. These findings suggest that to
achieve accurate results staff should be educated but most
importantly monitored and encouraged through an
appropriate line of management. The failure to see
improvements in blood culture performance during 2004
we believe reflects the low priority given by staff to the
performance of blood cultures, the difficulties in finding
resources and lack of encouragement and feedback to
first-contact clinical staff from their immediate line man-
agers. By having a small team of nurses, closely moni-
tored, in daily communication with the laboratory and
nurse manager and working towards targets, performance
was improved. The resources to undertake work were also
more easily controlled and always available. We conclude
by suggesting that a minimum set of standards requiredBMC Infectious Diseases 2008, 8:137 http://www.biomedcentral.com/1471-2334/8/137
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for adequate surveillance should be established. These
should incorporate an audit of blood culture quality and
blood volume collection, and a clear line of responsibility
for supervising blood culture collection suitable for local
circumstances in order to enhance the accuracy and relia-
bility of collected data.
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